ALDEYRA THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-22.3M | $-18.7M | $-12.1M | $-5.2M | $13.1M |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $37.8K | $35.8K | $18.8K | $1.1K | — |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $2.7M | $2.8M | $2.2M | $2.0M | $1.7M |
| Net Cash from Operating Activities | $-19.2M | $-15.1M | $-9.3M | $-4.8M | $-1.7M |
| Investing Activities | |||||
| Capital Expenditures | $24.8K | $11.8K | $86.1K | $14.1K | — |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-10.2M | — | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $37.4M | — | — | — | — |
| Net Change in Cash | $8.0M | $-2.6M | $6.1M | $5.3M | $2.0M |
| Free Cash Flow | $-19.2M | $-15.2M | $-9.4M | $-4.8M | — |